Skip to main content
Top

Clinical and Translational Oncology

Issue 11/2015

Content (15 Articles)

Review Article

Salivary gland myoepithelial carcinoma

S. Vilar-González, K. Bradley, J. Rico-Pérez, P. Vogiatzis, D. Golka, A. Nigam, M. Sivaramalingam, S. Kazmi

Research Article

Adjuvant treatment with infusional 5-fluorouracil in high risk adenocarcinoma of the stomach or gastroesophageal junction

N. Martínez-Lago, M. Vieito-Villar, Y. Vidal-Insua, M. E. Padin-Iruegas, F. Vazquez-Rivera, S. Candamio-Folgar, R. Lopez-Lopez

Research Article

Adjuvant regimens with trastuzumab administered for small HER2-positive breast cancer in routine clinical practice

S. Antolín-Novoa, E. Blanco-Campanario, A. Antón, M. I. Gallegos-Sancho, R. Pérez-Carrión, I. Peláez, A. Galán-Brotons, L. de la Cruz-Merino, A. Murías-Rosales

Research Article

Hepatic arterial infusion plus systemic chemotherapy as third-line or later treatment in colorectal liver metastases

W.-G. Qiang, L.-R. Shi, X.-D. Li, Q.-Q. Wu, J.-M. Zhao, L.-J. Chen, Y. Yang, J. Wu, M. Ji, C.-P. Wu

Research Article

MicroRNA-197 influences 5-fluorouracil resistance via thymidylate synthase in colorectal cancer

Z. Sun, N. Zhou, Q. Han, L. Zhao, C. Bai, Y. Chen, J. Zhou, R. C. Zhao

Open Access Research Article

Autologous tumor lysate/Bacillus Calmette–Guérin immunotherapy as an adjuvant to conventional breast cancer therapy

J. Convit, H. Montesinos, H. Oviedo, G. Romero, B. Maccarone, E. Essenfeld, A. Convit, L. E. Palacios

Research Article

Systemic chemotherapy as a main strategy for liver metastases from gastric cancer

W. Zhang, Y. Yu, Y. Fang, Y. Wang, Y. Cui, K. Shen, T. Liu

Research Article

The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival

B. B. Oven Ustaalioglu, O. Balvan, A. Bilici, A. Develi, M. Aliustaoglu, F. A. Vardar, B. Erkol

Research Article

miR-448 negatively regulates ovarian cancer cell growth and metastasis by targeting CXCL12

Y. Lv, Y. Lei, Y. Hu, W. Ding, C. Zhang, C. Fang

Research Article

Surgery combined with chemotherapy for recurrent gastric cancer achieves better long-term prognosis

F. Kong, Y. Qi, H. Liu, F. Gao, P. Yang, Y. Li, Y. Jia

Research Article

Effectiveness and toxicity of helical tomotherapy for patients with locally recurrent nasopharyngeal carcinoma

F. Puebla, J. L. Lopez Guerra, J. M. Garcia Ramirez, R. Matute, I. Marrone, C. Miguez, D. Sevillano, A. Sanchez-Reyes, E. Rivin del Campo, J. M. Praena-Fernandez, I. Azinovic

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine